Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration ...

The US government has cancelled a $590 million Moderna deal for a bird flu vaccine over safety and ethical concerns about ...

Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

The question of life's origin on Earth continues to surprise. A new study challenges an old idea: that a chemical reaction ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

“You share 50 percent of your DNA with each of your parents. But with bananas, we share about 50 percent of our genes,” Mike ...

“While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile ...

Roche raised the curtain on its novel approach to DNA sequencing earlier this year, and now it's working with the Broad ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...